{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:09:27Z","timestamp":1790665767228,"version":"4.1.0"},"reference-count":85,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.nephro.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T08:01:25Z","timestamp":1458806485000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["N\u00e9phrotoxicit\u00e9 du t\u00e9nofovir"],"prefix":"10.1684","volume":"12","author":[{"given":"Corinne","family":"Isnard-Bagnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Aloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Tourret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2016.01.002_bib0430","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis\u00a0B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0435","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4\u00a0years","volume":"21","author":"Nelson","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0440","first-page":"118","article-title":"Editorial comment: tenofovir nephrotoxicity-the disconnect between clinical trials and real-world practice","volume":"19","author":"Atta","year":"2009","journal-title":"AIDS Read"},{"key":"10.1016\/j.nephro.2016.01.002_bib0445","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0450","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00002030-200304110-00026","article-title":"Renal lesions in HIV-1-positive patient treated with tenofovir","volume":"17","author":"Creput","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0455","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure. Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0460","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1086\/379829","article-title":"Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine","volume":"37","author":"Rollot","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0465","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00365540310016169","article-title":"Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1","volume":"36","author":"Breton","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0470","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0163-4453(03)00082-3","article-title":"Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir","volume":"47","author":"Callens","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.nephro.2016.01.002_bib0475","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1359\/jbmr.2004.19.5.714","article-title":"Fanconi's syndrome in HIV+ adults: report of three cases and literature review","volume":"19","author":"Earle","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nephro.2016.01.002_bib0480","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00002030-200401230-00035","article-title":"Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution","volume":"18","author":"Gaspar","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0485","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3109\/00365548.2011.577805","article-title":"Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature","volume":"43","author":"Haverkort","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0490","first-page":"114","article-title":"Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3\u00a0cases","volume":"19","author":"Irizarry-Alvarado","year":"2009","journal-title":"AIDS Read"},{"key":"10.1016\/j.nephro.2016.01.002_bib0495","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1592\/phco.24.4.415.33182","article-title":"Tenofovir-related nephrotoxicity: case report and review of the literature","volume":"24","author":"James","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nephro.2016.01.002_bib0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1752-1947-2-94","article-title":"Acute renal failure in an AIDS patient on tenofovir: a case report","volume":"2","author":"Kapitsinou","year":"2008","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.nephro.2016.01.002_bib0505","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1016\/j.jinf.2004.08.031","article-title":"Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment-case report and review of literature","volume":"51","author":"Malik","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.nephro.2016.01.002_bib0510","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1111\/j.1525-1497.2006.00518.x","article-title":"Acquired Fanconi's syndrome associated with tenofovir therapy","volume":"21","author":"Mathew","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0515","first-page":"357","article-title":"Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature","volume":"15","author":"Quimby","year":"2005","journal-title":"AIDS Read"},{"key":"10.1016\/j.nephro.2016.01.002_bib0520","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","volume":"117","author":"Rifkin","year":"2004","journal-title":"Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/apc.2007.0052","article-title":"Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system","volume":"22","author":"Gupta","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0530","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QAI.0b013e3181d05579","article-title":"Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men","volume":"55","author":"Wever","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0535","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0540","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfh658","article-title":"Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study","volume":"20","author":"Izzedine","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2016.01.002_bib0545","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1468-1293.2005.00308.x","article-title":"Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study","volume":"6","author":"Antoniou","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0550","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/dkm064","article-title":"No change in calculated creatinine clearance after tenofovir initiation among Thai patients","volume":"59","author":"Gayet-Ageron","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nephro.2016.01.002_bib0555","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/135965350701200110","article-title":"Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir\/ritonavir","volume":"12","author":"Gerard","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nephro.2016.01.002_bib0560","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/apc.2005.19.421","article-title":"Low frequency of renal function impairment during one-year of therapy with tenofovir-containing regimens in the real-world: a case-control study","volume":"19","author":"Padilla","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0565","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1310\/2TAJ-QPD1-TYAE-QAK5","article-title":"Serious renal impairment occurs rarely with use of tenofovir DF","volume":"7","author":"Scott","year":"2006","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.nephro.2016.01.002_bib0570","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopha.2007.04.008","article-title":"Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project","volume":"62","author":"Madeddu","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nephro.2016.01.002_bib0575","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/01.qai.0000138983.45235.02","article-title":"Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study","volume":"37","author":"Jones","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0580","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/428840","article-title":"Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment","volume":"40","author":"Gallant","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1293.2006.00349.x","article-title":"Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy","volume":"7","author":"Winston","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0590","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002030-200501030-00012","article-title":"Antiretroviral therapy with tenofovir is associated with mild renal dysfunction","volume":"19","author":"Mauss","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0595","doi-asserted-by":"crossref","first-page":"e26042","DOI":"10.1371\/journal.pone.0026042","article-title":"Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil","volume":"6","author":"Menezes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nephro.2016.01.002_bib0600","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ncpneph0806","article-title":"Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults","volume":"4","author":"Ortiz","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nephro.2016.01.002_bib0605","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.nephro.2016.01.002_bib0610","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study","volume":"207","author":"Ryom","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.nephro.2016.01.002_bib0615","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2352-3018(15)00211-8","article-title":"Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study","volume":"3","author":"Mocroft","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.nephro.2016.01.002_bib0620","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.beem.2010.11.003","article-title":"Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity","volume":"25","author":"Cotter","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2016.01.002_bib0625","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/QAI.0b013e3181caebaa","article-title":"Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency","volume":"54","author":"Rosenvinge","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0630","first-page":"354908","article-title":"Tenofovir nephrotoxicity: 2011\u00a0update","volume":"2011","author":"Fernandez-Fernandez","year":"2011","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.nephro.2016.01.002_bib0635","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/aid.2009.0308","article-title":"Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users","volume":"26","author":"Childs","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.nephro.2016.01.002_bib0640","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0052","article-title":"Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir","volume":"28","author":"Masia","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.nephro.2016.01.002_bib0645","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.4076\/1752-1947-3-8136","article-title":"Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report","volume":"3","author":"Di Biagio","year":"2009","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.nephro.2016.01.002_bib0650","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-1293.2005.00318.x","article-title":"The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy","volume":"6","author":"Parsonage","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.nephro.2016.01.002_bib0655","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/RHU.0b013e31819c20d8","article-title":"Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient","volume":"15","author":"Perrot","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.nephro.2016.01.002_bib0660","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijid.2004.09.010","article-title":"Fatal lactic acidosis associated with tenofovir and abacavir","volume":"9","author":"Giola","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0665","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1592\/phco.24.11.1089.36138","article-title":"Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate","volume":"24","author":"Guo","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nephro.2016.01.002_bib0670","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/00365540410027157","article-title":"Severe metabolic acidosis and renal failure in an HIV-1\u00a0patient receiving tenofovir","volume":"36","author":"Hansen","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0675","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.327.7417.711","article-title":"Drug points: fatal lactic acidosis associated with tenofovir","volume":"327","author":"Rivas","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.nephro.2016.01.002_bib0680","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.inf.0000076600.83640.3e","article-title":"Fatal lactic acidosis and mimicking Guillain-Barre syndrome in an adolescent with human immunodeficiency virus infection","volume":"22","author":"Rosso","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.nephro.2016.01.002_bib0685","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1755-6686.2011.00209.x","article-title":"Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection","volume":"37","author":"Aperis","year":"2011","journal-title":"J Ren Care"},{"key":"10.1016\/j.nephro.2016.01.002_bib0690","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2016.01.002_bib0695","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3181a666eb","article-title":"Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats","volume":"51","author":"Lebrecht","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0700","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/pgs.09.115","article-title":"Pharmacogenetics of tenofovir treatment","volume":"10","author":"Rodriguez-Novoa","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.nephro.2016.01.002_bib0705","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":"Mechanism of active renal tubular efflux of tenofovir","volume":"50","author":"Ray","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2016.01.002_bib0710","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/labinvest.2011.48","article-title":"Tenofovir renal proximal tubular toxicity is regulated By OAT1\u00a0and MRP4\u00a0transporters","volume":"91","author":"Kohler","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.nephro.2016.01.002_bib0715","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.nephro.2016.01.002_bib0720","first-page":"199","article-title":"Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management","volume":"16","author":"Gutierrez","year":"2014","journal-title":"AIDS Rev."},{"issue":"2","key":"10.1016\/j.nephro.2016.01.002_bib0725","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol."},{"key":"10.1016\/j.nephro.2016.01.002_bib0730","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nephro.2016.01.002_bib0735","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nephro.2016.01.002_bib0740","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/135965350601100108","article-title":"Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy","volume":"11","author":"Cote","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nephro.2016.01.002_bib0745","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135965350501000110","article-title":"Tubular cell apoptosis and cidofovir-induced acute renal failure","volume":"10","author":"Ortiz","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nephro.2016.01.002_bib0750","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jbspin.2010.11.007","article-title":"Normal plasma FGF23\u00a0levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease","volume":"78","author":"Saidenberg-Kermanac\u2019h","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.nephro.2016.01.002_bib0755","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.2008.252","article-title":"Rosiglitazone reverses tenofovir-induced nephrotoxicity","volume":"74","author":"Liborio","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2016.01.002_bib0760","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1523-1755.2004.00359.x","article-title":"Down-regulation of Na+ transporters and AQP2\u00a0is responsible for acyclovir-induced polyuria and hypophosphatemia","volume":"65","author":"Andrade","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2016.01.002_bib0765","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/QAD.0b013e32833202e2","article-title":"Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations","volume":"24","author":"Rodriguez-Novoa","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0770","series-title":"Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir concentration?","year":"2011"},{"key":"10.1016\/j.nephro.2016.01.002_bib0775","doi-asserted-by":"crossref","first-page":"e22661","DOI":"10.1371\/journal.pone.0022661","article-title":"Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients","volume":"6","author":"Nishijima","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nephro.2016.01.002_bib0780","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/499048","article-title":"Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions","volume":"42","author":"Zimmermann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0785","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/524061","article-title":"Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy","volume":"197","author":"Goicoechea","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0790","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/QAD.0b013e3281fc9320","article-title":"Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir","volume":"21","author":"Crane","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.nephro.2016.01.002_bib0795","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/clpt.2008.140","article-title":"Lack of evidence for an effect of lopinavir\/ritonavir on tenofovir renal clearance","volume":"84","author":"Ray","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nephro.2016.01.002_bib0800","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.qai.0000242461.35768.45","article-title":"Renal function in patients receiving tenofovir with ritonavir\/lopinavir or ritonavir\/atazanavir in the HIV Outpatient Study (HOPS) cohort","volume":"43","author":"Buchacz","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0805","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/135965350701200211","article-title":"Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors","volume":"12","author":"Cihlar","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.nephro.2016.01.002_bib0810","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1128\/AAC.00437-06","article-title":"In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells","volume":"50","author":"Vidal","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2016.01.002_bib0815","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":"Association between ABCC2\u00a0gene haplotypes and tenofovir-induced proximal tubulopathy","volume":"194","author":"Izzedine","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0820","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0825","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e31815e7478","article-title":"Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients","volume":"47","author":"Kiser","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nephro.2016.01.002_bib0830","series-title":"N\u00e9phrotoxicit\u00e9 des antir\u00e9troviraux autres que le t\u00e9nofovir. EMC N\u00e9phrologie 18-066-H-20","author":"Tourret","year":"2014"},{"key":"10.1016\/j.nephro.2016.01.002_bib0835","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2016.01.002_bib0840","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11904-011-0082-8","article-title":"Vitamin\u00a0D in HIV-infected patients","volume":"8","author":"Lake","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.nephro.2016.01.002_bib0845","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5414\/CNP71567","article-title":"Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction","volume":"71","author":"Morelle","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2016.01.002_bib0425","first-page":"245","article-title":"Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis","volume":"19","author":"Psevdos","year":"2009","journal-title":"AIDS Read"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2016.01.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:24:38Z","timestamp":1741191878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725516000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1769725516000201"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2016.01.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9phrotoxicit\u00e9 du t\u00e9nofovir","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}